Clinical Trial Update: An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of a single dosage of Paliperidone ER in adults with schizophrenia; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone ER (paliperidone)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2010-02-26